Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Cash from Investing Activities (2020 - 2024)

Immuneering has reported Cash from Investing Activities over the past 5 years, most recently at $5.5 million for Q4 2024.

  • Quarterly results put Cash from Investing Activities at $5.5 million for Q4 2024, up 75.26% from a year ago — trailing twelve months through Dec 2024 was $26.4 million (up 262.3% YoY), and the annual figure for FY2025 was -$88.7 million, down 435.69%.
  • Cash from Investing Activities for Q4 2024 was $5.5 million at Immuneering, up from -$5.4 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for IMRX hit a ceiling of $22.2 million in Q2 2022 and a floor of -$52.8 million in Q3 2021.
  • Median Cash from Investing Activities over the past 5 years was $1.6 million (2020), compared with a mean of -$5398.8.
  • Biggest five-year swings in Cash from Investing Activities: crashed 941746.24% in 2021 and later skyrocketed 111852.97% in 2022.
  • Immuneering's Cash from Investing Activities stood at -$38058.0 in 2020, then crashed by 59829.41% to -$22.8 million in 2021, then skyrocketed by 135.74% to $8.2 million in 2022, then tumbled by 61.57% to $3.1 million in 2023, then surged by 75.26% to $5.5 million in 2024.
  • The last three reported values for Cash from Investing Activities were $5.5 million (Q4 2024), -$5.4 million (Q3 2024), and $5.0 million (Q2 2024) per Business Quant data.